Complete Filing Data
Talon Capital Corp. reported Stockholders Equity of -$7.24 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Talon Capital Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Net Income Loss | $383.9K | -$37.3K |
| Operating Income Loss | -$159.1K | -$37.3K |
| Payment Of Operating Expenses Through Advances From Related Party | $10.4K | |
| Nonoperating Income Expense | $543.0K | |
| General And Administrative Expense | $37.3K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stockholders Equity | -$7.2M |
| Retained Earnings Accumulated Deficit | -$7.2M |
| Liabilities Current | $128.7K |
| Liabilities And Stockholders Equity | $255.1M |
| Deferred Offering Costs Included In Accrued Offering Costs | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.9M |
| Assets Current | $3.0M |
| Assets | $255.1M |
| Accrued Offering Costs | $75.0K |
| Temporary Equity Accretion To Redemption Value | |
| Liabilities | $10.3M |
| Deferred Underwriting Fee Noncurrent | $10.2M |
| Cash Withdrawn From Trust Account For Working Capital Purposes | $75.9K |
| Assets Held In Trust Noncurrent | $252.1M |
| Accounts Payable And Accrued Liabilities Current | $53.7K |
| Other Receivables Net Current | |
| Deferred Costs | |
| Accrued Liabilities Current |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Stockholders Equity | -$7.1M | -$12.3K |
| Retained Earnings Accumulated Deficit | -$7.1M | -$37.3K |
| Liabilities Current | $168.5K | $320.1K |
| Liabilities And Stockholders Equity | $252.9M | $307.8K |
| Deferred Offering Costs Included In Accrued Offering Costs | $259.8K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $48.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.1M | $48.0K |
| Assets Current | $3.4M | $48.0K |
| Assets | $252.9M | $307.8K |
| Accrued Offering Costs | $75.0K | $259.8K |
| Temporary Equity Accretion To Redemption Value | $17.0M | |
| Liabilities | $10.4M | |
| Deferred Underwriting Fee Noncurrent | $10.2M | |
| Cash Withdrawn From Trust Account For Working Capital Purposes | ||
| Assets Held In Trust Noncurrent | $249.4M | |
| Accounts Payable And Accrued Liabilities Current | $70.6K | |
| Other Receivables Net Current | $185.1K | |
| Deferred Costs | $259.8K | |
| Accrued Liabilities Current | $26.8K |
Cash Flow Statement
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Share Based Compensation | $74.0K | |
| Proceeds From Related Party Debt | $23.0K | |
| Proceeds From Issuance Of Common Stock | $25.0K | |
| Net Cash Provided By Used In Financing Activities | $48.0K | |
| Increase Decrease In Accrued Liabilities | $26.8K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Preferred Stock Shares Authorized | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | |
| Weighted Average Number Of Diluted Shares Outstanding | |
| Sale Of Stock Number Of Shares Issued In Transaction | |
| Earnings Per Share Diluted | |
| Earnings Per Share Basic | |
| Common Stock Par Or Stated Value Per Share |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Preferred Stock Shares Authorized | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 7.5M | |
| Weighted Average Number Of Diluted Shares Outstanding | 7.5M | |
| Sale Of Stock Number Of Shares Issued In Transaction | 779.0K | |
| Earnings Per Share Diluted | $0.00 | |
| Earnings Per Share Basic | $0.00 | |
| Common Stock Par Or Stated Value Per Share | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Stock Issued During Period Value New Issues | |
| Investment Income Interest | |
| Stock Issued During Period Value Sale Of Private Placement Units | |
| Prepaid Insurance | $77.5K |
| Prepaid Expense Other Noncurrent | $51.7K |
| Operating Costs And Expenses | |
| Adjustments To Additional Paid In Capital Warrant Issued | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | |
| Adjustments To Additional Paid In Capital Mark To Market | |
| Other Prepaid Expense Current | $3.4K |
| Additional Paid In Capital |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 |
|---|---|---|
| Stock Issued During Period Value New Issues | $25.0K | |
| Investment Income Interest | $617.0K | |
| Stock Issued During Period Value Sale Of Private Placement Units | $7.8M | |
| Prepaid Insurance | $77.5K | |
| Prepaid Expense Other Noncurrent | $71.0K | |
| Operating Costs And Expenses | $159.1K | |
| Adjustments To Additional Paid In Capital Warrant Issued | $1.8M | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $122.7K | |
| Adjustments To Additional Paid In Capital Mark To Market | $74.0K | |
| Other Prepaid Expense Current | ||
| Additional Paid In Capital | $24.1K |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.